Literature DB >> 31210311

LncRNA FBXL19-AS1 promotes proliferation and metastasis via regulating epithelial-mesenchymal transition in non-small cell lung cancer.

D-J Yu1, Y-H Li, M Zhong.   

Abstract

OBJECTIVE: To detect the relative expression of long non-coding ribonucleic acid (lncRNA) F-box and leucine-rich repeat protein 19-antisense RNA 1 (FBXL19-AS1) in tissues and cells of non-small-cell lung cancer (NSCLC), and investigate the mechanism of lncRNA FBXL19-AS1 in promoting NSCLC cell proliferation and metastasis by regulating epithelial-mesenchymal transition (EMT) via in vitro experiments. PATIENTS AND METHODS: The relative expression of lncRNA FBXL19-AS1 in NSCLC tissues and cells was detected via quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). The colony formation assay was performed to study the impact of interference with lncRNA FBXL19-AS1 expression on NSCLC cell proliferation. The flow cytometry was applied to determine the influence of si-FBXL19-AS1 on the cycle distribution of NSCLC cells. After the interference with lncRNA FBXL19-AS1 expression, the transwell assay was utilized to measure the changes in the migratory and invasive abilities of NSCLC cells, while the expression changes in EMT-related molecular markers was detected via Western blotting.
RESULTS: The results of qRT-PCR showed that the expression of lncRNA FBXL19-AS1 in NSCLC tissues and cells was up-regulated. According to the results of the colony formation assay, the proliferative capacity of NSCLC cells was decreased after the interference with lncRNA FBXL19-AS1 expression. In flow cytometry, it was indicated that the cell cycle was arrested at the G0/G1 phase in the experimental group compared with that in the control group. The transwell assay results showed that the migratory and invasive abilities of NSCLC cells were weakened after the interference with lncRNA FBXL19-AS1 expression. The results of the Western blotting assay revealed that the expressions of EMT-related molecular markers (E-cadherin, N-cadherin, etc.) were changed.
CONCLUSIONS: The expression of lncRNA FBXL19-AS1 in NSCLC tissues and cells is up-regulated, and the highly expressed lncRNA FBXL19-AS1 can promote NSCLC cell proliferation and metastasis by regulating the EMT.

Entities:  

Year:  2019        PMID: 31210311     DOI: 10.26355/eurrev_201906_18065

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  7 in total

1.  IGF2BP2 stabilized FBXL19-AS1 regulates the blood-tumour barrier permeability by negatively regulating ZNF765 by STAU1-mediated mRNA decay.

Authors:  Xiaobai Liu; Peiqi Wu; Rui Su; Yixue Xue; Chunqing Yang; Di Wang; Xuelei Ruan; Jian Zheng; Yang Yang; Zhen Li; Yunhui Liu
Journal:  RNA Biol       Date:  2020-07-25       Impact factor: 4.652

2.  Long Noncoding RNA FBXL19-AS1 Expedites Cell Growth, Migration and Invasion in Cervical Cancer by miR-193a-5p/PIN1 Signaling.

Authors:  Su Wan; Guantai Ni; Jin Ding; Yuansheng Huang
Journal:  Cancer Manag Res       Date:  2020-10-07       Impact factor: 3.989

3.  LncRNA GAS5 expression in non-small cell lung cancer tissues and its correlation with Ki67 and EGFR.

Authors:  Yihui Fu; Lirong Liu; Jiabin Zhan; Huijuan Zhan; Chun Qiu
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

4.  Identify and Validate the Transcriptomic, Functional Network, and Predictive Validity of FBXL19-AS1 in Hepatocellular Carcinoma.

Authors:  Dingdong He; Xiaokang Zhang; Xinyu Zhu; Narayani Maharjan; Yingchao Wang; Ping Luo; Chunzi Liang; Jiancheng Tu
Journal:  Front Oncol       Date:  2020-12-03       Impact factor: 6.244

5.  Long non‑coding RNA PITPNA‑AS1 silencing suppresses proliferation, metastasis and epithelial‑mesenchymal transition in non‑small cell lung cancer cells by targeting microRNA‑32‑5p.

Authors:  Gang Chen; Zhifeng Zheng; Junsheng Li; Peigang Zhang; Zhenjun Wang; Shiping Guo; Jun Ma; Jian Shen; Huixin Li
Journal:  Mol Med Rep       Date:  2021-01-26       Impact factor: 2.952

6.  LncRNA SNHG14 contributes to the progression of NSCLC through miR-206/G6PD pathway.

Authors:  Lin Zhao; Xiaodong Zhang; Yantong Shi; Tianlu Teng
Journal:  Thorac Cancer       Date:  2020-03-09       Impact factor: 3.500

7.  LncRNA TMPO-AS1 facilitates the proliferation and metastasis of NSCLC cells by up-regulating ERBB2 via sponging miR-204-3p.

Authors:  Xiaobo Yu; Qiang Lin; Fabing Liu; Fu Yang; Jingyu Mao; Xi Chen
Journal:  Int J Immunopathol Pharmacol       Date:  2020 Jan-Dec       Impact factor: 3.219

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.